A patient with a diagnosis of chronic myeloid leukemia has met with her oncologist, who has recommended treatment with the kinase inhibitor imatinib. What route of administration should the nurse explain to the patient?
A) Daily intramuscular injections throughout the course of treatment
B) Peripheral IV administration three times a day for 7 to 10 days
C) Weekly IV infusions over 6 to 8 hours through a central line
D) Oral administration of imatinib in a home setting
D
You might also like to view...
A student nurse has been asked by the registered nurse with whom the student nurse is working to apply wrist restraints to a patient who is confused and is trying to remove the endotracheal tube
The student nurse knows that it is important to tie the restraints to which part of the bed? a. Side rails b. Part of bed frame that moves up and down with the patient c. Footboard d. Headboard
The nurse instructs a group of community members on the difference between benign and malignant neoplasms. Which participant statements indicate that teaching has been effective?
Select all that apply. A) "Benign tumors grow slowly." B) "Malignant tumors are easy to remove." C) "Benign tumors stay in one area." D) "Malignant tumors push other tissue out of the way." E) "Malignant tumors can grow back."
Which statement best fits a request for proposal (RFP) for a wireless system?
1. The vendor sends literature about its wireless system to several institutions to increase their business. 2. The search committee sends email requests to several vendors stating the needs of the institution for a new wireless system. 3. The steering committee sends a formal document to several vendors to ask for specific information about their wireless system. 4. A formal document is sent by a vendor who heard an institution is upgrading its monitoring system.
The movement of substances across cell membranes using chemical energy and carrier molecules is called:
a. active transport b. diffusion c. filtration d. osmosis